SYNGR1 and Alzheimer disease: While no profound alterations were detected in the levels of CPLX1, SYT1, SYNGR1 and VAMP2 in any of the other studied hippocampal sub-regions of AD patients, the plasma membrane protein STX1A showed increased immunostaining in the CA4 (Fig. 2).